This inventor holds 3 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent. Top assignee: Venenum Biodesign, LLC. Active years: 2021-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2023
Title: **An Overview of Inventor Venugopalareddy Bommireddy Venkata**
Introduction
Venugopalareddy Bommireddy Venkata is an accomplished inventor based in Princeton Junction, NJ, USA, recognized for his significant contributions to the field of medicinal chemistry. With a total of three patents to his name, his work primarily focuses on innovative compounds that show promise in therapeutic applications.
Latest Patents
Venkata's latest patents include groundbreaking inventions related to substituted pyrrolo[1,2-a]pyrazines and pyrrolo[1,2-a][1,4]diazepines, specifically designed as TREX1 inhibitors. These patents outline compounds formulated to modulate the TREX1 protein, which can be utilized as medicaments for treating or preventing disorders that are affected by the inhibition of TREX1. This innovative work is poised to have a major impact on therapeutic strategies in the related medical fields.
Career Highlights
Currently, Venugopalareddy Bommireddy Venkata is affiliated with Venenum Biodesign, LLC, where he applies his expertise in drug design and development. His commitment to advancing medical science through innovative inventions has positioned him as a valuable asset in his field, contributing to research that could lead to significant medical breakthroughs.
Collaborations
Throughout his career, Venkata has collaborated with talented individuals like Jeffrey John Letourneau and Kiruthika Selvarangan Elamparuthi. These partnerships exemplify the collaborative nature of research and development in the industry, highlighting how teamwork can lead to successful innovations.
Conclusion
Venugopalareddy Bommireddy Venkata stands out as a significant figure in the realm of innovation, with a focus on developing treatments that take advantage of molecular interactions within the body. His ongoing work at Venenum Biodesign, LLC, alongside his esteemed colleagues, not only reflects his dedication to scientific advancement but also promises to contribute positively to the healthcare sector.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile